ALX Oncology
ALXO
ALXO
114 hedge funds and large institutions have $2.55B invested in ALX Oncology in 2021 Q3 according to their latest regulatory filings, with 26 funds opening new positions, 34 increasing their positions, 34 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
2.73% more ownership
Funds ownership: 82.81% → 85.54% (+2.7%)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
0% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 34
Holders
114
Holding in Top 10
4
Calls
$5.77M
Puts
$1.84M
Top Buyers
| 1 | +$71.7M | |
| 2 | +$41.1M | |
| 3 | +$37.5M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$9.59M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$9.06M |
Top Sellers
| 1 | -$24.1M | |
| 2 | -$14.6M | |
| 3 | -$14.3M | |
| 4 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
-$14.2M |
| 5 |
FCMV
Foresite Capital Management V
Larkspur,
California
|
-$12.6M |